These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 31070522)

  • 1. Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India.
    Alladi CSH; Jagadesh A; Prabhu SG; Arunkumar G
    Viral Immunol; 2019 Jun; 32(5):230-233. PubMed ID: 31070522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of Circulating Antibodies against the Hemagglutinins of Influenza Viruses in the 2022/2023 Epidemic Season in Poland.
    Kondratiuk K; Poznańska A; Szymański K; Czajkowska E; Mańkowski B; Brydak LB
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland.
    Kondratiuk K; Hallmann E; Szymański K; Łuniewska K; Poznańska A; Brydak LB
    Acta Biochim Pol; 2024; 71():12289. PubMed ID: 38721309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic drift and immunity gap explain reduction in protective responses against influenza A(H1N1)pdm09 and A(H3N2) viruses during the COVID-19 pandemic: a cross-sectional study of human sera collected in 2019, 2021, 2022, and 2023.
    Fossum E; Rohringer A; Aune T; Rydland KM; Bragstad K; Hungnes O
    Virol J; 2024 Mar; 21(1):57. PubMed ID: 38448981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Protective Antibodies Against Influenza and the Reduction of the Influenza Incidence Rate: An Annual Repeated Cross-Sectional Study From 2014 to 2019.
    Guiomar R; Pereira da Silva S; Costa I; Conde P; Cristóvão P; Rodrigues AP; Fernandes A; Dias AP; Couto AR; Ramos A; Moita C; Rodrigues C; Vale F; Caldeira F; Bruges Armas J; Pereira-Vaz J; Alves J; Freitas L; Martins L; Milho L; Mota-Vieira L; Lopes L; Freitas M; Pessanha MA; Correia M; Marques MH; Cardoso MJ; Peres MJ; Cunha M; Amantegui P; Mota P; Lopes P; Pereira P; Viseu R; Cabral R; Côrte-Real R; Almeida S; Soares V; Mansinho K; Hungnes O; Nunes B
    Influenza Other Respir Viruses; 2024 May; 18(5):e13307. PubMed ID: 38798072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
    Morrison BJ; Martin NJ; Rehman T; Ewing D; Dewar RL; Metcalf J; Sun P; Beigel J; Luke TC; Raviprakash K
    BMC Health Serv Res; 2018 Aug; 18(1):651. PubMed ID: 30134892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
    Skowronski DM; Hottes TS; McElhaney JE; Janjua NZ; Sabaiduc S; Chan T; Gentleman B; Purych D; Gardy J; Patrick DM; Brunham RC; De Serres G; Petric M
    J Infect Dis; 2011 Jan; 203(2):158-67. PubMed ID: 21288814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study.
    Chen MI; Barr IG; Koh GC; Lee VJ; Lee CP; Shaw R; Lin C; Yap J; Cook AR; Tan BH; Loh JP; Barkham T; Chow VT; Lin RT; Leo YS
    PLoS One; 2010 Aug; 5(8):e12474. PubMed ID: 20814575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.
    Ng S; Saborio S; Kuan G; Gresh L; Sanchez N; Ojeda S; Harris E; Balmaseda A; Gordon A
    Vaccine; 2017 Oct; 35(45):6202-6207. PubMed ID: 28986036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Mediated Suppression Regulates the Humoral Immune Response to Influenza Vaccination in Humans.
    Lu X; Liu F; Tzeng WP; York IA; Tumpey TM; Levine MZ
    J Infect Dis; 2024 Feb; 229(2):310-321. PubMed ID: 37981659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.
    INSIGHT FLU005 IVIG Pilot Study Group
    J Infect Dis; 2016 Feb; 213(4):574-8. PubMed ID: 26374911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection.
    Lu X; Guo Z; Li ZN; Holiday C; Liu F; Jefferson S; Gross FL; Tzeng WP; Kumar A; York IA; Uyeki TM; Tumpey T; Stevens J; Levine MZ
    Sci Rep; 2022 Sep; 12(1):14971. PubMed ID: 36056075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to influenza A(H1N1)pdm infection.
    Wraith S; Nachbagauer R; Balmaseda A; Stadlbauer D; Ojeda S; Rajabhathor A; Lopez R; Guglia AF; Sanchez N; Amanat F; Gresh L; Kuan G; Krammer F; Gordon A
    Vaccine; 2020 Jun; 38(27):4221-4225. PubMed ID: 32389495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study.
    Waldock J; Remarque EJ; Zheng L; Ho S; Hoschler K; Neumann B; Sediri-Schön H; Trombetta CM; Montomoli E; Marchi S; Lapini G; Zhou F; Lartey SL; Cox RJ; Facchini M; Castrucci MR; Friel D; Ollinger T; Caillet C; Music N; Palladino G; Engelhardt OG;
    Front Immunol; 2023; 14():1155552. PubMed ID: 37143658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the potential of blood donation archives for influenza surveillance and control.
    Zhang Y; Leung K; Perera RAPM; Lee CK; Peiris JSM; Wu JT
    PLoS One; 2020; 15(5):e0233605. PubMed ID: 32470010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response during influenza virus infection among the population of Assam, Northeast India.
    Dutta M; Dutta P; Medhi S; Borkakoty B; Biswas D
    Indian J Med Microbiol; 2019; 37(4):549-556. PubMed ID: 32436879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life course exposures continually shape antibody profiles and risk of seroconversion to influenza.
    Yang B; Lessler J; Zhu H; Jiang CQ; Read JM; Hay JA; Kwok KO; Shen R; Guan Y; Riley S; Cummings DAT
    PLoS Pathog; 2020 Jul; 16(7):e1008635. PubMed ID: 32702069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of glutaraldehyde-fixed turkey red blood cells for influenza virus detection after 18 months of storage.
    Pawar SD; Tare DS; Kode SS; Keng SS
    J Virol Methods; 2023 Dec; 322():114830. PubMed ID: 37783397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanophotonic detection of freely interacting molecules on a single influenza virus.
    Kang P; Schein P; Serey X; O'Dell D; Erickson D
    Sci Rep; 2015 Jul; 5():12087. PubMed ID: 26160194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection.
    Del Rosario JMM; da Costa KAS; Asbach B; Ferrara F; Ferrari M; Wells DA; Mann GS; Ameh VO; Sabeta CT; Banyard AC; Kinsley R; Scott SD; Wagner R; Heeney JL; Carnell GW; Temperton NJ
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.